These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 26971081)

  • 41. Changing paradigm of cryptococcal meningitis: an eight-year experience from a tertiary hospital in South India.
    Abhilash KP; Mitra S; Arul JJ; Raj PM; Balaji V; Kannangai R; Thomas SA; Abraham OC
    Indian J Med Microbiol; 2015; 33(1):25-9. PubMed ID: 25559998
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of trypan blue stain in a haemocytometer for rapid detection of cerebrospinal fluid sterility in HIV patients with cryptococcal meningitis.
    Kwizera R; Akampurira A; Kandole TK; Nielsen K; Kambugu A; Meya DB; Boulware DR; Rhein J;
    BMC Microbiol; 2017 Aug; 17(1):182. PubMed ID: 28830348
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cryptococcal meningitis with atypical paradoxical inflammatory reactions after antifungal treatment in acquired immune deficiency syndrome: A case report.
    Samukawa S; Yoshimi R; Kojitani N; Uzawa Y; Takase-Minegishi K; Kirino Y; Soejima Y; Kato H; Nakajima H
    J Infect Chemother; 2023 Mar; 29(3):347-352. PubMed ID: 36384196
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study.
    Bicanic T; Meintjes G; Rebe K; Williams A; Loyse A; Wood R; Hayes M; Jaffar S; Harrison T
    J Acquir Immune Defic Syndr; 2009 Jun; 51(2):130-4. PubMed ID: 19365271
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A paradoxical decline: intracranial lesions in two HIV-positive patients recovering from cryptococcal meningitis.
    Pettersen KD; Pappas PG; Chin-Hong P; Baxi SM
    BMJ Case Rep; 2015 Oct; 2015():. PubMed ID: 26475880
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early ART After Cryptococcal Meningitis Is Associated With Cerebrospinal Fluid Pleocytosis and Macrophage Activation in a Multisite Randomized Trial.
    Scriven JE; Rhein J; Hullsiek KH; von Hohenberg M; Linder G; Rolfes MA; Williams DA; Taseera K; Meya DB; Meintjes G; Boulware DR;
    J Infect Dis; 2015 Sep; 212(5):769-78. PubMed ID: 25651842
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of quantitative CSF microscopy to predict culture status and outcome in HIV-associated cryptococcal meningitis in a Brazilian cohort.
    Vidal JE; Gerhardt J; Peixoto de Miranda EJ; Dauar RF; Oliveira Filho GS; Penalva de Oliveira AC; Boulware DR
    Diagn Microbiol Infect Dis; 2012 May; 73(1):68-73. PubMed ID: 22578940
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)-report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS Clinical Trials Group.
    Lalloo UG; Komarow L; Aberg JA; Clifford DB; Hogg E; McKhann A; Bukuru A; Lagat D; Pillay S; Mave V; Supparatpinyo K; Samaneka W; Langat D; Ticona E; Badal-Faesen S; Larsen RA;
    PLoS One; 2023; 18(2):e0281580. PubMed ID: 36780493
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda: a cross-sectional study.
    Oyella J; Meya D; Bajunirwe F; Kamya MR
    J Int AIDS Soc; 2012 Mar; 15(1):15. PubMed ID: 22417404
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Different presentations and outcomes between HIV-infected and HIV-uninfected patients with Cryptococcal meningitis.
    Liao CH; Chi CY; Wang YJ; Tseng SW; Chou CH; Ho CM; Lin PC; Ho MW; Wang JH
    J Microbiol Immunol Infect; 2012 Aug; 45(4):296-304. PubMed ID: 22608531
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preventing deaths from cryptococcal meningitis: from bench to bedside.
    Roy M; Chiller T
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):715-7. PubMed ID: 21905781
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reproducibility of CSF quantitative culture methods for estimating rate of clearance in cryptococcal meningitis.
    Dyal J; Akampurira A; Rhein J; Morawski BM; Kiggundu R; Nabeta HW; Musubire AK; Bahr NC; Williams DA; Bicanic T; Larsen RA; Meya DB; Boulware DR;
    Med Mycol; 2016 May; 54(4):361-9. PubMed ID: 26768372
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
    Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E;
    Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cerebrospinal Fluid Culture Positivity and Clinical Outcomes After Amphotericin-Based Induction Therapy for Cryptococcal Meningitis.
    Rolfes MA; Rhein J; Schutz C; Taseera K; Nabeta HW; Huppler Hullsiek K; Akampuira A; Rajasingham R; Musubire A; Williams DA; Thienemann F; Bohjanen PR; Muzoora C; Meintjes G; Meya DB; Boulware DR
    Open Forum Infect Dis; 2015 Dec; 2(4):ofv157. PubMed ID: 26716103
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A preliminary study on the characteristics of Th1/Th2 immune response in cerebrospinal fluid of AIDS patients with cryptococcal meningitis.
    Li A; Zhu W; Yin J; Huang X; Sun L; Hua W; Wang W; Zhang T; Dai L; Wu H
    BMC Infect Dis; 2021 May; 21(1):500. PubMed ID: 34051748
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early mycological treatment failure in AIDS-associated cryptococcal meningitis.
    Robinson PA; Bauer M; Leal MA; Evans SG; Holtom PD; Diamond DA; Leedom JM; Larsen RA
    Clin Infect Dis; 1999 Jan; 28(1):82-92. PubMed ID: 10028076
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Optimal timing for antiretroviral therapy initiation in patients with HIV infection and concurrent cryptococcal meningitis.
    Njei B; Kongnyuy EJ; Kumar S; Okwen MP; Sankar MJ; Mbuagbaw L
    Cochrane Database Syst Rev; 2013 Feb; (2):CD009012. PubMed ID: 23450595
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Parenteral and oral fluconazole for acute cryptococcal meningitis in AIDS: experience with thirteen patients.
    Stern JJ; Pietroski NA; Buckley RM; Braffman MN; Rinaldi MG
    Ann Pharmacother; 1992; 26(7-8):876-82. PubMed ID: 1504391
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled study.
    Bussel JB; de Miguel PG; Despotovic JM; Grainger JD; Sevilla J; Blanchette VS; Krishnamurti L; Connor P; David M; Boayue KB; Matthews DC; Lambert MP; Marcello LM; Iyengar M; Chan GW; Chagin KD; Theodore D; Bailey CK; Bakshi KK
    Lancet Haematol; 2015 Aug; 2(8):e315-25. PubMed ID: 26688484
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A retrospective study of AIDS-associated cryptomeningitis.
    Sachdeva RK; Randev S; Sharma A; Wanchu A; Chakrabarti A; Singh S; Varma S
    AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1220-6. PubMed ID: 22369456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.